Moderna
MRNA
#1214
Rank
โ‚น1.794 T
Marketcap
โ‚น4,592
Share price
0.46%
Change (1 day)
56.27%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -โ‚น270.01 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น2.20 Billion. In 2024 the company made an earning of -โ‚น325.7 Billion, an increase over its 2023 earnings that were of -โ‚น354.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น270.01 Billion-17.1%
2024 -โ‚น325.7 Billion-8.22%
2023 -โ‚น354.88 Billion-140.65%
2022 โ‚น873.01 B-27.81%
2021 โ‚น1.209 T-1911.15%
2020 -โ‚น66.77 Billion44.7%
2019 -โ‚น46.15 Billion28.63%
2018 -โ‚น35.88 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.944 T-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.486 T-619.94%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น2.098 T-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น4.32 Billion-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น10.7 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น3.8 Billion-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.84 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น12.80 B-104.48%๐Ÿ‡บ๐Ÿ‡ธ USA